{
  "description": null,
  "compose": {
    "include": [ {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept": [ {
        "code": "200327",
        "display": "capecitabine 150 MG Oral Tablet"
      }, {
        "code": "200328",
        "display": "capecitabine 500 MG Oral Tablet"
      } ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113762.1.4.1116.210.json",
  "package_name": "us.nlm.vsac",
  "date": "2022-01-12T01:02:12-05:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "12",
    "lastUpdated": "2022-01-12T01:02:12.000-05:00"
  },
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: This value set contains concepts that represent the medication Capecitabine.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; oral Capecitabine.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "name": "CapecitabineOral",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 2,
    "contains": [ {
      "code": "200327",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "capecitabine 150 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "200328",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "capecitabine 500 MG Oral Tablet",
      "version": "11062023"
    } ],
    "timestamp": "2023-12-10T21:35:27-05:00",
    "identifier": "urn:uuid:be1e7514-0f2c-42cd-8062-5eb6516d0a58"
  },
  "title": "Capecitabine Oral",
  "package_version": "0.17.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "American Society of Clinical Oncology Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2023-04-06"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2022-01-12"
  } ],
  "status": "active",
  "id": "e9f1cc1c-1227-4897-8343-a2a41451cd7c",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113762.1.4.1116.210",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20220112"
}